| |
| |
|
| Insider
Information: |
Atkinson Edward Morrow Iii |
| Relationship: |
EVP, Chief Technical O... |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
15,972 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,348,551 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
15,972 |
|
|
| Total
Value |
$6,348,551 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
89bio, Inc. |
ETNB |
|
2023-06-01 |
0 |
2023-03-01 |
0 |
Premium* |
|
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Chief Technical O... |
2024-02-26 |
15,972 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Technical Ops. Off. |
• – – |
2024-02-26 |
4 |
AS |
$425.70 |
$375,893 |
D/D |
(883) |
15,972 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Technical Ops. Off. |
• – – |
2024-02-23 |
4 |
D |
$431.79 |
$714,181 |
D/D |
(1,654) |
16,855 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Technical Ops. Off. |
• – – |
2024-02-21 |
4 |
AS |
$421.77 |
$506,546 |
D/D |
(1,201) |
18,509 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Technical Ops. Off. |
• – – |
2024-02-20 |
4 |
AS |
$420.79 |
$337,053 |
D/D |
(801) |
19,710 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Technical Ops. Off. |
• – – |
2024-02-20 |
4 |
D |
$420.58 |
$473,153 |
D/D |
(1,125) |
20,511 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Technical Ops. Off. |
• – – |
2024-02-16 |
4 |
D |
$424.01 |
$636,439 |
D/D |
(1,501) |
21,636 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Technical Ops. Off. |
• – – |
2024-02-12 |
4 |
AS |
$420.24 |
$383,679 |
D/D |
(913) |
23,137 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Technical Ops. Off. |
• – – |
2024-02-09 |
4 |
D |
$422.74 |
$351,720 |
D/D |
(832) |
24,050 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Technical Ops. Off. |
• – – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,743 |
24,882 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Technical Ops. Off. |
• – – |
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,260 |
20,139 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Technical Ops. Off. |
• – – |
2023-08-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,879 |
|
% |
|
| ETNB |
89bio, Inc. |
|
– • – |
2023-06-01 |
4 |
AS |
$17.91 |
$111,938 |
D/D |
(6,250) |
0 |
0 |
% |
|
| ETNB |
89bio, Inc. |
|
– • – |
2023-06-01 |
4 |
OE |
$2.61 |
$16,313 |
D/D |
6,250 |
6,250 |
0 |
- |
|
| ETNB |
89bio, Inc. |
Director |
– • – |
2023-03-01 |
4 |
AS |
$13.60 |
$136,000 |
D/D |
(10,000) |
0 |
0 |
% |
|
| ETNB |
89bio, Inc. |
Director |
– • – |
2023-03-01 |
4 |
OE |
$4.44 |
$44,400 |
D/D |
10,000 |
10,000 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
